ClinicalTrials.Veeva

Menu

Beyond TME Origins

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Neoplasms
Carcinoma
Adenocarcinoma

Treatments

Procedure: New Radiological Staging Classification system for patients with advanced and recurrent colorectal cancer undergoing pelvic exenterative surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT02292641
DOCUMAS: 17HH4158

Details and patient eligibility

About

All patients with recurrent colorectal cancer in the pelvis are eligible. The original primary tumour staging scans and resected surgical specimen needs to be available. Patients' recurrence will be staged using our proposed MRI classification. We will be assessing the original primary staging scans and histopathology to learn about risk factors for recurrence. We will record treatment for the recurrence, and patients will be followed up for three years.

Full description

A prospective and retrospective cohort study to improve surgical and treatment planning using an imaging assessment proforma of advanced and recurrent colorectal cancers. This involves the implementation of imaging assessment proformas describing anatomic pelvic compartments and aetiology of disease recurrence for treatment planning.

Enrollment

383 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Had a primary colorectal adenocarcinoma proven by biopsy taken as part of routine clinical practice
  2. Has a confirmed diagnosis of recurrent pelvic colorectal cancer
  3. Has previously completed surgical treatment of primary adenocarcinoma of the colon, sigmoid colon or rectum
  4. Are able to undergo high resolution MRI for staging prior to treatment decisions
  5. Have provided written informed consent to participate in the study
  6. Be aged 16 years or over

Exclusion criteria

  1. Have irresectable extra-pelvic metastatic disease
  2. Original baseline staging and preoperative restaging scans (MR for rectal and sigmoid cancers and/or CT for colon and sigmoid cancers) are unavailable
  3. Original preoperative, surgical and adjuvant treatment has not been documented or is unavailable

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

383 participants in 1 patient group

Patients with pelvic recurrence from primary colorectal cancer
Other group
Description:
Implementation of imaging assessment proformas describing anatomic pelvic compartments and aetiology of disease recurrence for treatment planning.
Treatment:
Procedure: New Radiological Staging Classification system for patients with advanced and recurrent colorectal cancer undergoing pelvic exenterative surgery

Trial contacts and locations

4

Loading...

Central trial contact

Syvella Ellis; Caroline Martin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems